|
Market Closed -
Euronext Paris
11:55:00 2026-11-02 EST
|
5-day change | 1st Jan Change | ||
| 0.4350 EUR | -1.14% |
|
-3.76% | +11.25% |
| 10-06 | WINNERS & LOSERS: Celebrus warning; Kenmare gets takeover interest | AN |
| 09-30 | Novacyt S.A., H1 2026 Earnings Call, Sep 30, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Medical Devices
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 35.62M | - | - | |||
| 63.77B | |||||
| 56.37B | |||||
| 54.62B | |||||
| 44.06B | |||||
| 42.11B |
- Stock Market
- Stocks
- ALNOV Stock
- Charts Novacyt
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
